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ABSTRACT
In New Mexico, the mortality rate due to diabetes is 1.5 times higher than the
nation. Diabetes causes a huge healthcare burden. In 2012, the national cost due to
diabetes was $245 billion. Prior studies have established a positive correlation
between vitamin D deficiency and diabetes; whether the same relationship holds for
prediabetes is not well studied. Our purpose of the study was to find whether there was
an association between vitamin D deficiency and prediabetes. We also wanted to find
out if the association was stronger among Hispanics than non-Hispanic whites (NHW).
Our rationale was to delay the progression of diabetes by preventing at a prediabetes
stage with vitamin D supplementation in deficient population. In New Mexico, there are
106,310 adults diagnosed with prediabetes which is 7% of our population. Therefore, it
is crucial that a preventive measure is in place to impede the progression of diabetes
among a vulnerable population where there is a high rate of diabetes, obesity and
vitamin D deficiency.
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We planned to conduct our research with a cross-sectional study design. To do
this we randomly selected 200 subjects from New Mexico Elder Health Survey 19931995, containing only Medicare recipients of Albuquerque. The participants were 65
years and older, containing non-Hispanic whites (55%) and Hispanics (45%) with
relatively equal subjects with normal fasting plasma glucose and prediabetes. There
were equal number of males and females. Also there were equal distributions of normal
and deficient vitamin D level among our study subjects.
From our statistical analyses, we found there was no association between
vitamin D deficiency and prediabetes. However, when we conducted multivariable
logistic regression analysis with interaction between Hispanic ethnicity and vitamin D
deficiency with prediabetes as outcome, we found that Hispanics with vitamin D
deficiency were 2.4 fold increased odds for having prediabetes as compared to NHW.
Our findings are innovative, interesting and novel which will provide rationale for
future research on vitamin D and prediabetes.
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CHAPTER 1: INTRODUCTION
Background
Prediabetes
Prediabetes is an early stage in the continuum of diabetes where plasma glucose
is elevated but not high enough to be classified as diabetes. Prediabetes is also
known as impaired glucose tolerance or impaired fasting glucose. The criteria for
diagnosis of prediabetes are based on either fasting plasma glucose (FPG)
between 100 mg/dL and 125 mg/dL or hemoglobin A1c level, a measure of
average glucose over 2 month period is between 5.7% and 6.4% (1). In 2010,
an estimated 79 million American adults aged 20 years and older were
diagnosed with prediabetes. Individuals with prediabetes are up to 5-15 times
more likely to develop diabetes than individuals with normal blood glucose levels
(2). According to data from the telephone-based New Mexico Behavioral Risk
Factor Surveillance System (BRFSS) survey, 7.0% or 106,310 of New Mexico
adults aged 18 and older had diagnosed prediabetes in 2008-2010 (3).

Diabetes
Diabetes is a major public health problem. Several risk factors including higher
body mass index (BMI), family history, diet and sedentary lifestyle habits play a
role in the pathogenesis of diabetes. The national cost of diabetes in the U.S. in
2012 exceeds $245 billion constituting a huge health care burden. This includes
a direct cost of $176 billion accounting for all medical expenses and an indirect
cost of $69 billion for loss of productivity from unemployment and disability due to
1

diabetes (4). In New Mexico the 8.3% overall rate of diabetes is similar to that of
nation but the mortality rate from diabetes in New Mexico is 1.5 times higher (4).
Recent research indicates vitamin D is intimately related to diabetes. Vitamin D
may delay the progression of diabetes at an early stage (5). National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK), a division of National
Institute of Health (NIH) has proposed $5 million for the Fiscal Year 2013
Presidential Budget request to a support multicenter study to test whether vitamin
D can prevent diabetes in high risk adults (5).
There are a number of study findings that demonstrate a positive correlation
between vitamin D deficiency and diabetes in humans. A study by Johnson et
al. suggested the mechanism behind this relationship occurs due to the presence
of vitamin D receptors (VDR) on pancreatic β cells in the islets of Langerhans (6).
In addition, other research supports a direct effect of vitamin D on insulin
synthesis and secretion because of the presence of the vitamin D response
element in the human insulin gene promoter and the transcriptional activity of the
human insulin gene caused by 1, 25-dihydroxyvitamin D, the active form of
vitamin D (7, 8). A positive correlation has been demonstrated between serum
vitamin D concentration and insulin sensitivity index wherein low serum vitamin D
was associated with increased risk for insulin resistance (9). Previously studies
have established that a positive correlation exists between vitamin D deficiency
and diabetes. The potential mechanism behind the pathogenesis of diabetes
was described by Pittas et al. after a systematic review analysis of 44 literature
studies involving observational studies and randomized control trials concluded
2

that there was a direct effect of vitamin D on insulin secretion. The reason was
attributed to the mechanism where vitamin D binding to VDRs on β cells causes
an influx of calcium through the calcium channels which influences the insulin
filled vesicles to be released via exocytosis into plasma to maintain the
homeostasis of glucose. They concluded that alteration in vitamin D level
impaired the insulin release that caused a disturbance in the homeostasis of
plasma glucose resulting in diabetes. Thus it was reasonable to propose that
people with type 2 diabetes have low vitamin D as has been suggested by
observational study findings (10) (Figure 1).

Fig 1. Potential Mechanism: Pathogenesis of Diabetes
Vit D

Pittas et al. 2007, Journal of Clinical Endocrin Metab

In addition to a direct effect, an indirect effect of vitamin D on the pancreatic β
cell may be mediated through its regulation of calcium that in turn affects insulin
secretion, which is a calcium dependent process (11). Is there an association of
vitamin D deficiency with prediabetes among Elderly New Mexicans? The
association between vitamin D deficiency and diabetes is well documented (7, 8,
3

9, 12). However, little is known about whether such an association exists with
prediabetes. Further, the link between vitamin D deficiency in New Mexico
population and diabetes is poorly studied. We proposed a cross-sectional study
to evaluate the association between vitamin D deficiency and prediabetes among
Hispanic and non-Hispanic white New Mexicans. Our research objective was to
determine if there is an association between vitamin D deficiency and
prediabetes in our New Mexico population. This population is ideal to carry out
this research as New Mexico has a relatively large number of individuals with
diabetes (4) and has an ethnically diverse population with equal distribution of
Hispanics and non-Hispanic whites (13) and increased rate of vitamin D
deficiency (14). Persons of Hispanic ethnicity have been found to have high
rates of vitamin D deficiency (15).

If we found an association between vitamin

D deficiency and prediabetes then simple preventive measure such as vitamin D
supplements might prevent progression to diabetes (16).

Vitamin D Background
It was estimated that 24% of the U.S. population is at risk of vitamin D
inadequacy (12-20 ng/mL), and 8% are at risk of vitamin D deficiency (≤ 12
ng/mL) (48) (Fig 2). Vitamin D is a fat soluble vitamin that is primarily
synthesized in skin from direct sunlight.

4

Fig 2

The majority of vitamin D in adults is synthesized in the epidermis of the skin
accounting for more than 80% of total previtamin D3 (17). The synthesis of
vitamin D occurs when ultraviolet (UV) B radiation with a wavelength of 290-320
nanometers penetrates uncovered skin and converts cutaneous 7dehydrocholesterol to previtamin D3, which in turn becomes vitamin D3 (11).
Only a small amount (30%) is obtained from the diet (12). The best dietary
sources of vitamin D are fatty fish such as salmon, tuna and mackerel and fish
liver oils. Also small amounts of vitamin D are found in beef liver, cheese, egg
yolks and vitamin D fortified foods (18).
It has been suggested by vitamin D researchers that approximately 5-30 minutes
of sun exposure between 10 AM and 3 PM at least twice a week to the face,
5

arms, legs or back without sunscreen usually lead to sufficient vitamin D
synthesis (18). Vitamin D must go through a series of two hydroxylation
processes to produce the biologically active form of vitamin D, 1,25(OH)2D (19).
The first hydroxylation process occurs in the liver and forms 25(OH)D and the
second hydroxylation step occurs in the kidney to form the active vitamin D,
1,25(OH)2D (Fig 3 ). The active form of vitamin D then binds to vitamin D
binding protein and reaches target organs containing vitamin D receptors (20).
In summary, vitamin D receptors are present on β cells and that vitamin D is
essential for pancreatic β cell to secretion of insulin and is responsible for insulin
sensitivity. Therefore, vitamin D deficiency leads to β cell dysfunction that
impairs the homeostasis of plasma glucose.

6

Fig 3

Vitamin D Synthesis

Diabetes, Obesity and Metabolism, 2008

Fig 3

Diagnosis Criteria
The best indicator for vitamin D status is 25(OH)D because it reflects both
cutaneous production as well as from food and supplement intake (18) and it has
a slower rate of clearance than the active form 1,25(OH)2D (12).
Potential Predictors of Vitamin D Deficiency
1. Skin type - The type of skin a person possesses determines the vitamin D
level. The amount of previtamin D3 that can be synthesized in the skin from UVB
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radiation depends on skin type. According to Fitzpatrick scale (21), fair-skinned
individuals (skin types I/II), pale skin maximizes the use of any UV radiation in
weak sunlight for vitamin D3 synthesis. Whereas, in dark-skinned individuals
(skin types V/VI) (21), only a fraction of the available UVB reaches the skin cells
where 7-dehydroxycholesterol (7-DHC) conversion to previtamin D3 occurs (22).
Skin types III and IV are intermediate in their response to UV production of
vitamin D. An experimental study conducted by Chen et al. demonstrated that
the conversion of epidermal 7-DHC to previtamin D3 in Type II skin was
approximately 5-10 fold more efficient than highly pigmented type V skin (23).
This is due to the fact that melanin in dark skin types absorbs UV radiation
preventing the conversion of 7-DHC to previtamin D3 (22).
2. Ethnicity – Previous studies have noted that the prevalence of vitamin D
deficiency in Hispanics is higher than non-Hispanic whites. For instance, Forrest
et al. study demonstrated this by analyzing the NHANES (National Health and
Nutritional Examination Survey) data, 2005-2006 to evaluate the vitamin D
deficiency in the U.S. population particularly among minority population. They
concluded that the prevalence rate of vitamin D deficiency is highest among
Blacks (82.1%) followed by Hispanics (62.9%), and lowest in Whites (30%) (14).
Other studies have shown that vitamin D levels can differ by ethnicity with Blacks
and Hispanics consistently manifesting lower serum concentrations of vitamin D
than non-Hispanic whites (15). One possible mechanism is that the darker skin
pigmentation of Blacks and Hispanics inhibits cutaneous synthesis of
cholecalciferol, the metabolic precursor to vitamin D (25). Analysis of the
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National Health and Nutrition Examination Survey (NHANES), 2005 to 2006 data
were conducted to measure the overall prevalence rate of vitamin D deficiency.
The result from the data analysis found that African American adults had the
highest prevalence rate of vitamin D deficiency (82.1%; 95% CI, 76.5%-86.5%),
followed by Hispanic adults (62.9%; 95% CI, 53.2%-71.7%) and whites with the
lowest prevalence (30% at 95% CI) (14).
3. Age – Skin changes with aging. There is an age-dependent decrease in the
Fig 4. Layers of Human Skin

7-DHC in the stratum basale (Fig 4),
the actively reproducing layer of the
epidermis (26). The empirical finding
from UV exposure to skin samples of 8
and 18 year olds compared to subjects
77- and 82 year olds revealed a
dramatic decline in the ability of the
epidermis to produce previtamin D3.
This is attributed to the decreased

http://spaces.imperial.edu/thomas.morrell/cha_5_tortora_integument.htm

photosynthesizing capacity of previtamin D3 in the elderly as compared to that of
a young person (26). The highest rates of vitamin D deficiency (approximately
48%) were found in the age group between 55 to 64 years as compared to the
age group between 30-34 years that had the lowest rates of vitamin D deficiency
(approximately 36%) (14).
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4. Obesity – Obesity also has a role in vitamin D concentration. Obese
individuals (BMI≥30) have significantly lower circulating vitamin D than nonobese individuals. To demonstrate this, Blum et al. performed liquid
chromatography/mass spectrometry to measure the vitamin D level in the serum
and fat tissue of morbidly obese subjects undergoing gastric bypass surgery (27).
They found an inversely relationship associated with obesity and vitamin D
concentration (27). The inverse association was suggested to be due to the
adipose tissue acting as a repository for vitamin D by increased metabolic
clearance through enhanced uptake in fat tissue and/or decreased bioavailability
of vitamin D once it is deposited in fat tissue (27). Muscogiuri et al. investigated
the relationship between 25(OH)D concentration and insulin sensitivity and found
a significant correlation between 25(OH)D and BMI (r=-.58; P=001). In this
study BMI was found to be the most powerful predictor of vitamin D with a
correlation of -0.52, P<0.01) (28).

Gaps in knowledge and rationale of this study
This transition from prediabetes to diabetes may be due to either insulin
resistance and/or impaired beta cell function secreting insulin. Vitamin D
deficiency is related to the factors such as skin types, older age, and obesity
have been linked to incident diabetes suggesting that vitamin D replacement
might be a potential preventive measure for incipient diabetes. Vitamin D
deficiency is highly prevalent (18-50%) among the U.S. Hispanic population. If
we found a positive association between low vitamin D and high plasma glucose,
it could suggest a simple preventive intervention for diabetes in New Mexico.
10

Prior literature has suggested an association between vitamin D deficiency and
prediabetes (29). Our analysis will examine whether such an association exists
in a cohort of elderly Hispanics and NHW of New Mexico.

Significance
Diabetes represents a significant impact on quality of life and our national
healthcare economy. Therefore, by identifying whether there is an association
between vitamin D deficiency and prediabetes as measured by fasting plasma
glucose, we can inform and develop a prevention strategy for diabetes. The
proposed research has the potential to help prevent the progression of the
disease at an early stage, and thus could reduce health care costs attributed to
diabetes. Our research study will contribute to an understanding of the
association of fasting plasma glucose (FPG) and vitamin D status in a cohort of
older Hispanics and NHW of New Mexico. It has been estimated that each year
up to 11% of individuals with prediabetes will develop diabetes (30). Nazarian et
al. found that the insulin sensitivity improved in subjects with high-dose vitamin D
supplementation (10,000 IU) daily for four weeks delaying the progression to
diabetes (16). Vitamin D thus may be replenished with a simple inexpensive
intervention through improvements in nutrition or by predetermined exposure to
sunlight.

Innovation
Even though Hispanics have a higher prevalence rate of vitamin D deficiency, the
link between vitamin D deficiency and prediabetes is still unknown as are
differences in vitamin D deficiency between Hispanic and non-Hispanic white
11

populations in New Mexico. Our research study is innovative because it will help
to identify whether vitamin D deficiency is linked to prediabetes, which may
ultimately lead to a low risk intervention for the prevention of diabetes. New
Mexico is the ideal site for the conduct of this research because of the multiethnic population (Hispanic, non-Hispanic white, American Indian) and the
unique environment of low latitude and high altitude where UV exposure is high.
Our focus on Hispanic and non-Hispanic whites of New Mexico adds strength
because we can differentiate vitamin D deficiency in both groups and New
Mexico has a high proportion of Hispanic population which may increase the risk
for high prevalence of vitamin D deficiency and diabetes (3, 13). Our approach
would allow us to identify the association of vitamin D deficiency and prediabetes
in a highly vulnerable population with diabetes and skin types with different
degrees of melanin content (which can lead to reduced vitamin D synthesis),
where simple interventions are urgently needed to prevent the disease. We
utilized data from the New Mexico Elder Health Survey (NMEHS), where subjects
were randomly selected from the Medicare rolls of Bernalillo County,
Albuquerque.
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CHAPTER 2: MATERIALS AND METHODS
The data for this research study were extracted from New Mexico Elder Health
Survey (NMEHS) based on a Medicare beneficiary population. The NMEHS is
the first population based epidemiological survey to examine health and health
related issues of elderly (65 years and older) Hispanic and non-Hispanic white
residents in Bernalillo County, Albuquerque, New Mexico (31).

Data were

collected between May 1993 and September 1995. The survey was composed
of a two-tiered design consisting of a standardized home interview and an
extensive clinical examination. Initially a total of 2,200 names were randomly
selected from a listing of 50,700 individuals 65 years and older that was provided
by Health Care Financing Administration (HCFA) which administers the Medicare
program (31) (32).
The subjects’ information on age, sex and race was included in the HCFA listing.
Ethnicity was assigned based on surname pattern by GUESS (Generally Useful
Ethnic Search System), a computerized program. Ethnic heritage was confirmed
by self-report from participating subjects. Of these 2,200 subjects, 534 had died,
moved, could not be contacted or were otherwise found to be ineligible. Of the
remaining eligible subjects, 1,130 (67.8 percent) completed the home interview
and 883 (53 percent) (Fig 5) completed the full physical examination and formed
the basis of our sample.

Two samples of blood were drawn at the time of

physical exam where the fasting plasma glucose was measured and vials of
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centrifuged sera samples were stored in a freezer in the Molecular Epidemiology
laboratory at the University Of New Mexico (UNM) for future
Fig 5

102 Missing Key Variables

781 Complete Records

200 Randomly Selected
for Analysis

use. Other information such as body mass index (BMI) was also measured
during physical examination.

All subjects gave informed consent, and all

procedures approved by Human Research Review Committee of the UNM,
14

School of Medicine (31).

All data in this study were de-identified and thus

exempt from human subjects’ considerations.

Fasting Plasma Glucose
Fasting plasma glucose (FPG) is categorized according to American Diabetes
Association (ADA) (Fig 6) as follows:

Fig 6 ADA Classification of FPG
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The ADA criterion uses hemoglobin A1c level for diagnosis of diabetes which is a
measure of average plasma glucose over the 2-3 month period. Since we were
presented only with FPG level, we grouped our study subjects into two
categories normal and prediabetes based on FPG. When FPG is less than 100
mg/dL it is considered as normal; between 100 mg/dL and 125 mg/dL is
considered as prediabetes.

Vitamin D
The lifespan of vitamin D levels in sera are substantially stable for well over 20
years (personal reference Dr. Ronald Hurst, Heartland Assays, Ames, Iowa)
when stored at -80○ celsius. We therefore utilized the stored vials of frozen sera
containing at least a minimum of 125 µL. The sera samples were placed in dry
ice for maintaining the integrity of the samples and were shipped out to Heartland
Assays, Ames, Iowa, one of the reputed laboratories for vitamin D measurement
in the nation.

Vitamin D levels were measured using chemi-luminescent

immunoassay and the levels were expressed in ng/mL.
Vitamin D levels were initially categorized into 3 groups (Table 1) according to
Institute of Medicine (IOM) criteria: Normal (20 ng/mL and above), Inadequate
(12 ng/mL to 20 ng/mL) and Deficient (less than or equal to 12 ng/mL).

Table 1 Institute of Medicine Classification of Vitamin D Levels
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Because the number of vitamin D belonging to deficient strata was very small
(n=28), we combined inadequate with deficient group for a better power to the
study.

Therefore, in lieu of 3 categories of vitamin D, we analyzed into 2

categories: normal (≥20 ng/mL) and deficient (<20 ng/mL) vitamin D groups.

BMI
The study subjects were categorized according to CDC classification into 3
groups (Table 2): Normal BMI (18.5-24.9); Overweight BMI (25.0-29.9) and
Obese BMI (≥30).
Table 2 CDC† Classification of BMI

Age, Sex and Ethnicity
The study subjects are composed of both males and female participants with
distribution of Hispanics and non-Hispanic whites of New Mexico (Table 3).
Since the subjects were obtained from NMEHS containing only Medicare
recipients from Bernalillo County, Albuquerque, NM, every participant is 65 years
and older. We categorized age as follows:
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Table 3 -- Age distribution of ethnicity and gender of 200 study subjects
Category

Age range

NHW

Hisp

Males

Females

1

65-70 years

26

28

27

27

2

70-80 years

66

50

62

54

3

>80 years

18

12

14

16

Study Design
This is a cross-sectional study design. This study serves as a useful platform to
examine the association of vitamin D in prediabetes population. This is a crosssectional study design. For the present study, we excluded 102 subjects out of
883 participants because of missing data on key variables such as BMI and
glucose. This resulted in a total of 781 subjects (883-102). Due to the limited
available funding, we analyzed only 200 subjects (Fig 5) of the total 781 people.
We randomly selected 200 out of 799 subjects using STATA software program to
analyze the association of vitamin D deficiency and prediabetes. Vitamin D
levels were measured on these selected 200 subjects whose serum samples
were stored in the Molecular Epidemiology Laboratory, University of New Mexico,
Albuquerque, NM. Aliquots of these serum samples were analyzed by
Heartland Assay, Ames, Iowa, that specializes in vitamin D measurement.

For our study we wanted to analyze the association of vitamin D deficiency with
normal and prediabetes population. Our variables included in the study are:

18

fasting plasma glucose (FPG), vitamin D, body mass index (BMI), age, sex and
ethnicity. To do this, we conducted the following specific aims:
Aim 1: Determine the association between vitamin D deficiency and prediabetes
among elderly New Mexicans from a subset of NMEHS cohort.
Introduction for Aim 1: The objective of this research was to elucidate the
association between vitamin D deficiency and prediabetes, among the Hispanic
and non-Hispanic white New Mexican elderly population in the NMEHS. A
number of studies suggest an association exists between the vitamin D
deficiency and diabetes but no direct relationship has been established.
Moreover, little is known about the link between vitamin D and prediabetes. Our
study would thus allow us to determine whether vitamin D deficiency has an
association with prediabetes among the representing group of Hispanic and nonHispanic whites 65 years and older.
Data Analysis for Aim 1: Utilizing STATA, we performed univariate analysis
including frequency distributions; Pearson chi-square test to find association for
categorical variables; t-test to find mean values of continuous variables; simple
linear regression to find association between continuous variables; and
multivariable logistic regression analysis for categorical variables with
prediabetes as outcome to assess the odds ratios and the impact of multiple
variables including vitamin D level, sex, BMI, age and ethnicity.
Aim 2: Determine whether the association between vitamin D deficiency and
prediabetes is stronger among Hispanic than non-Hispanic whites from NMEHS
sample.

19

Introduction for Aim 2: The prevalence of diabetes is known to be higher
among Hispanics than non-Hispanics as is the vitamin D deficiency (2, 3, 4).
However, since Hispanics have different skin types than non-Hispanic whites (14,
25), attributable to melanin contents and melanin acts as a sunscreen reducing
the synthesis of vitamin D from ultraviolet B rays, we expected to find a stronger
association of vitamin D deficiency and prediabetes among Hispanics than nonHispanic whites in the NMEHS sample.
Data Analysis for Aim 2:
We used linear regression models to assess the association between continuous
variables; multivariable logistic regression analysis for vitamin D deficiency
(predictor) on prediabetes (outcome) by interaction model where BMI, gender,
age and ethnicity are covariates.
Sample Size and Power Analysis for Aim1: We used SAS Power Analysis to
calculate power of the study (Table 4). At a significance level of 0.05, a sample
size of 200 observations achieves 81% power to detect an OR of 2.25, when the
risk factor proportion is 50% and disease prevalence is 50%.
Table 4

Power Analysis

Number of
subjects

Significance
Level

Odds Ratio

Power

200

0.05

1.5

0.3

200

0.05

1.75

0.5

200

0.05

2.00

0.68

200

0.05

2.25

0.81

200

0.05

2.5

0.89
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Statistical Analyses
The data analyses were performed by using STATA software program (Stata
Corp, 4905 Lakeway Dr, College Station, TX 77845) and SAS 9.3 for windows
(SAS Institute Inc. Cary, NC).

Inclusion and Exclusion Criteria
Our population included Hispanics and non-Hispanic whites of 65 years and
older containing both males and females. Our study also contained subjects with
normal (≥20 ng/mL) and deficient (<20 ng/mL) levels of vitamin D (Table 5). We
excluded participants with hypoglycemic levels of glucose (FPG<60 mg/dL),
diabetes (FPG≥126mg/dL) and underweight BMI (<18.5).
Table 5 Criteria for Study Subjects
•

Inclusion Criteria
65 years and older

•

Exclusion Criteria
Missing values

•

Hispanics and NHW

•

BMI – underweight

•

Glucose
–
Prediabetes

•

Hypoglycemia and Diabetes

•

Vitamin D
Deficient

Normal

–

Normal

and

and

21

CHAPTER 3: AIM 1 RESULTS
The first aim of the study was to determine whether an association between vitamin D
deficiency and prediabetes exists. We hypothesized that vitamin D deficiency is
associated with increased odds for having prediabetes. To analyze the data for Aim 1,
we utilized STATA and SAS software program. We conducted descriptive analysis to
study the characteristics of the population, Pearson Chi-square test and linear
regression analysis to measure association between categorical and continuous
variables; and multivariable regression analysis for prediabetes as outcome measure.

Descriptive Analysis:
Study Population:
Our study subjects contained slightly higher percentage (55%) of non-Hispanic whites
(NHW) than Hispanics (45%) (Table 6). The participants were relatively equally
distributed among males (n=103) and females (n=97). The distribution of prediabetes
was slightly higher than 50% of the study population (n=103) and normal glucose
category was close to 50% of population (n=97).

Within the 3 categories of BMI

status, 38% belonged to normal weight, 44% were overweight and 18% were obese.
The distribution of vitamin D levels between normal (n=101) and deficient (n=99) status
were relatively equal.
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Table 6

Study Population Characteristics
NHW

Hispanics

Males

Females

Males

Females

27
34

27
22

18
24

25
23

26
25
10

17
21
11

14
22
6

19
20
9

Vitamin D Status
Normal
Deficient

44
17

21
28

27
15

9
39

Sex

61

49

42

48

Glucose Status
Normal
Prediabetes
BMI Status
Normal
Overweight
Obese

Table 7 Univariate Association of Continuous Predictor Variables with
Prediabetes
Normal Glucose

Prediabetes

Variable

Mean ± SD

Mean ± SD

p-value

Serum Vitamin D (ng/mL)

20.43 ± 8.32

20.99 ± 11.17

0.69

BMI (kg/m²)

25.36 ± 3.37

27.76 ± 4.18

<0.001

Age (years)

74.56 ± 5.72

73.49 ± 5.42

0.18

We analyzed the mean values of potential continuous predictors among the two
FPG statuses (Table 7). There was no significant difference in mean vitamin D
level between normal and prediabetes FPG. The average vitamin D values were
similar among normal glucose and prediabetic subjects (p-value=0.69). The
mean age distribution among these two FPG statuses also was similar and nonsignificant (p-value=0.18). Prediabetics had a statistically significant higher mean
23

BMI as compared to normal glucose subjects with lower mean BMI (pvalue=0.0001) though both BMI belonged to overweight category.
We then wanted to determine the measure of association, on explanatory
categorical variables, including vitamin D status and normal versus prediabetes
as determined by FPG by Pearson Chi-square test, a simple univariate analysis
(Table 8).

Table 8 Association of Categorical Variables with FPG Status
among 200 Randomly selected subjects with Vitamin D quantified
Normal
Glucose

Prediabetes

Total
Number

62%
50%
17%

38%
50%
83%

76
88
36

BMI
Normal Weight
Overweight
Obese
Vitamin D (ng/mL)
Normal

Deficient

0.398
46%
52%

54%
48%

101
99

Age (years)
60-70
70-80
≥80

0.332
41%
50%
57%

59%
50%
43%

54
116
30

Ethnicity
NHW
Hisp

0.853
49%
48%

51%
52%

110
90

Sex
Males
Females

Chi-sq
p-value
<0.0001

0.161
44%
54%

56%
46%

103
97

The distribution of vitamin D levels among normal and prediabetes groups were
not significantly different. We did find a statistically significant difference with
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BMI distribution between the prediabetes and normal glucose groups (pvalue<0.0001), where 83% were obese and prediabetic as compared to 17%
obese with normal glucose. Overall, the distribution of other covariates, age,
ethnicity and gender did not have significant association with glucose levels.
To analyze the relationship between two continuous variables, vitamin D levels
and fasting plasma glucose, we constructed a simple regression analysis (Fig 7 )
with and without the vitamin D outlier value (106.6 ng/mL).

Regression plot - glucose and vitamin D levels
Slope= -0.03
p-value=0.74

²

100

110

R = 0.0006

80

90

FPG
(mg/dL)
glucose
(mg/dL)

120

130

Fig 7 Regression Plot – FPG and Serum Vitamin D Level

10

20

30

40

50

Serum Vitamin
Vitamin DD (ng/mL)
(ng/mL)
glucose

The relationship between vitamin D excluding the outlier and FPG is displayed in
Figure 8, where regression line indicates a non-statistically significant slightly
negative relationship between the two variables (excluding outlier: slope = -0.03,
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p=0.74). When the outlier was included we saw a slightly positive relationship
not significant (slope=0.08, p=0.30). Vitamin D levels accounted for
approximately 0.06% of the variation in FPG (R²=0.0006). We included the
outlier value in the calculation wherever we analyzed vitamin D data as
categorical variable.
As previously described, we found that the distribution of BMI was significantly
different between FPG status groups, so to further explore this relationship we
performed a simple linear regression analysis between the two continuous
variables, BMI and FPG with latter as the outcome (Fig 8). There was a positive
relationship between the two variables (p-value<.001) where BMI accounted for
8% of the variation in glucose (R²=0.08).
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Multivariable Logistic Regression Analysis
To further explore the relationship between vitamin D and prediabetes, we
conducted a multivariable logistic regression analysis (Table 9) to adjust
vitamin D for other significant covariates.

Table 9 Multivariable Analysis – Prediabetes Outcome
Predictor Variables

Odds Ratio

95% CI

Vitamin D deficiency

0.88

(0.46, 1.69)

Hispanic Ethnicity

1.17

(0.64, 2.14)

BMI-Overweight

1.48

(0.78, 2.80)

BMI-Obese

8.06

(2.93, 22.20)

Additional covariates in the model are age & sex

From this analysis, we were unable to reject the null hypothesis for Aim 1
because we did not find an association between vitamin D deficiency and
prediabetes, OR=0.88, (CI .46, 1.69). This analysis found no increased odds for
having prediabetes in Hispanics; however the role ethnicity plays in prediabetes
is further discussed in the next chapter. BMI status had a significant role for
having prediabetes. In general our subjects who were obese had significantly
higher odds, OR=8.06, CI (2.93, 22.20) for having prediabetes than normal
weight subjects, whereas, overweight subjects were 1.48 times likely to develop
prediabetes than normal weight people, though not significantly associated.
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CHAPTER 4: AIM 2 RESULTS
The second aim of the study was to determine whether the degree of association
between vitamin D deficiency and prediabetes was stronger among Hispanics
than NHW. We hypothesized that the association would be stronger among
Hispanics than NHW elderly New Mexicans.
We analyzed the mean values of potential continuous predictors among the two
categories of ethnicities (Table 10).
Table 10 Association of Continuous Variables among Ethnic Groups
NHW

Hispanics

Mean ± SD

Mean ± SD

Serum Vitamin D (ng/mL)

22.3 ± 11.0

18.8 ± 8.0

0.01

Fasting Plasma Glucose
(mg/dL)
BMI (kg/m²)

99.4 ± 9.6

101.6 ± 12.0

0.15

26.7 ± 4.2

26.4 ± 3.7

0.61

Age (years)

74.4 ± 5.3

73.6 ± 5.8

0.30

p-value

The mean values of potential predictors among the two ethnic groups are listed
as above (Table 10). Hispanic subjects had a statistically significant lower mean
vitamin D level (18.8 ng/mL) which falls in the deficient range (p-value=0.01) as
compared to NHW with mean vitamin D level (22.3 ng/mL) in the normal range.
Previously Hispanics have been shown to have lower vitamin D level than NHW
(16). The mean values of fasting plasma glucose (FPG) for Hispanics was
slightly higher, but not statistically different than NHW ( p-value=0.15). Both
ethnic groups’ mean value of BMI status were similar and in the overweight
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category. Similarly the mean age (74 years) was equal among Hispanics and
NHW subjects.
We wanted to determine how the FPG was distributed among the two ethnic
groups based on their vitamin D status. Therefore we constructed box plots for
prediabetes as outcome variable with vitamin D and ethnicity as categorical
explanatory variables (Fig 9).

110
100
80

90

Glucose (mg/dL)

120

130

Fig 9 FPG Distribution
among NHW
& Hispanics
bywith
Vitamin
D status
Glucose Distribution
among
NHW andStratified
Hispanics
Vitamin
D

NHW

Hispanics

NHW

Normal Vitamin D

Hispanics

Vitamin D Deficient

When our sample was stratified by vitamin D levels, Hispanic and NHW
participants did not significantly differ in terms of BMI or age (Table 10). On the
other hand, among vitamin D deficient participants, the median glucose for
Hispanics with vitamin D deficiency was higher (102 mg/dL) than NHW (94
mg/dL) although not significant. However, the boxplot in Figure 10 indicated that
there may be an interaction between ethnicity and vitamin D levels and therefore
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we performed a multivariable logistic regression analysis including an interaction
term to adjust vitamin D for other significant covariates (Table 11).
Table 11

Multivariable Regression Analysis by Interaction – Prediabetes as
Outcome

Predictor Variable

Odds Ratio

95% CI

Hispanics with Vitamin D Deficiency vs
NHW with Vitamin D Deficiency
Overweight vs Normal Weight

2.42

(1.00, 5.85)

1.62

(0.84, 3.11)

Obese vs Normal Weight

9.17

(3.23, 26.03)

Age: 70-80 vs ≥65-70 years
≥80 vs ≥65-70 years

0.67
0.64

(0.33, 1.37)
(0.24, 1.69)

Female vs Male

0.57

(0.30, 1.10)

From the above analysis we found that Hispanics having vitamin D deficient
status is associated with 2.4 fold increased odds for prediabetes as compared to
NHW (p=0.02). Therefore, we reject the null hypothesis for Aim 2.
There was also significant finding among obese population more likely to have
prediabetes, OR=9.17, CI (3.23, 26.03) than normal weight people.
Table 12 Association of Vitamin D Levels with Age Category
Age category
Normal Vitamin D Deficient Vitamin D Chi-sq
p-value
=0.232
65-70 years
30
24
70-80 years

60

56

≥80 years

11

19

30

We wanted to evaluate whether age has an association with vitamin D level as
described by previous studies (18, 20). But we did not find a correlation among
increasing age and vitamin D deficiency (p-value=0.232) (Table 12).
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CHAPTER 5: DISCUSSION AND CONCLUSION

We aimed to determine whether there is an association between vitamin D
deficiency and prediabetes among New Mexico Elder Health Survey (NMEHS)
subjects. Our study found no association between vitamin D deficiency and
prediabetes opposite to our hypothesis for Aim 1. However, we did find that our
elderly New Mexican Hispanic subjects with vitamin D deficiency had a 2.4 fold
increased risk for pre-diabetes, as we had hypothesized for Aim 2. This finding
indicates that there may be a cumulative effect of risk factors influencing the
outcome more than the individual factors acting independently. Hispanics were
significantly more likely to be vitamin D deficient, and those who were deficient
were more likely to be prediabetic.
One reason for the lack of an association between vitamin D deficiency and
prediabetes as hypothesized in Aim 1 could be the small sample size (N=200),
although our power analysis did indicate that we would have 81% to detect a
2.25-fold increased risk if the risk factor constituted 50% of the sample. The
result may be different when the rest of the sample is analyzed (N=581) as a
larger sample size would have more power to detect the relationship better
between the low vitamin D and prediabetes than a smaller study group.
Hispanic subjects’ mean vitamin D level compared to NHW was significantly
lower and this may be due to predisposing factors such as darker skin types with
some genetic factor with the Hispanic ethnicity itself leading to the deficiency.
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This finding is in agreement with previous research work by Chen et al. (14) and
Forrest et al. (18).
Obesity was another risk factor that appeared to play a significant role in
prediabetes independently. According to the 2009-2010 National Health and
Nutrition Examination Survey (NHANES), 35.7% of American adults were obese
(26). Nevertheless, our elderly population’s obesity rate in 1993-1995 was half
the prevalence rate (18%) compared to the 2009-2010 national data.
Age as was described in previous studies by MacLaughlin et al. and Forrest et al.
as a risk factor for lower serum vitamin D level. But in our study, age was not
associated with low serum vitamin D. However, as all subjects were 65 years or
older, the age range was possibly too narrow to see a difference. It may also be
possible that the older age groups used daily vitamin D supplements or vitamin D
fortified food that helped to maintain their levels. Our analysis on increasing age
and its association with vitamin D deficiency did not correlate to earlier study
findings as suggested by MacLaughlin where increasing age caused a decrease
in DHC content in the stratum basale that led to lower vitamin D synthesis (20). ).
But we did not see such a trend consistent with age (Table 12). Also another
study by Forrest et al. found that older adults were more vitamin D deficient than
younger adults (18).
Limitations
This is a cross-sectional study design; therefore, the data are only valid for
associations and not causal effects. Our study was limited to the evaluation of
associations of vitamin D deficiency and prediabetes with elderly subjects of 65
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years and older. It is not certain whether the results of our study can be applied
to a younger population. In addition, as we only studied Hispanics and NHW in
New Mexico generalizability to other races such as African Americans or Asians
or other Hispanic sub-groups is limited. Since New Mexico gets sunlight most of
the year, comparison of our study to similar subjects located at different latitudes
may not be applicable where there is limited sunshine at lower elevation.
Our study is a preliminary analysis of small sample size (N=200). To obtain a
more definitive evaluation of our hypotheses, we need to examine the complete
sample size of 581 subjects. Our power analysis demonstrated that we could
detect an odds ratio of 2.25 between the prediabetes and normal subjects and
the odds ratio we found was 2.42, so that we may have missed associations with
lower estimates of effect.
There was missing information from our data set that possibly could restrict our
findings. For example, residual confounding could take place by unmeasured
variables such as hemoglobin A1c values, sun exposure, vitamin D intake,
lactose intolerance status and whether subjects were on medications that would
impair vitamin D metabolism such as steroids, cholestyramine, phenobarbital or
phenytoin. Also, the duration of prediabetes or vitamin D deficiency in this
population is unknown, and this might determine the severity of the disease.
Strengths
Because ours is a cross-sectional study where the data had already been
carefully collected, it was less expensive to conduct and quicker to analyze than
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a longitudinal cohort study. There are reasons why our findings may be
generalizable with external validity. Because we selected 200 subjects randomly
from a community based population, we have less chance for selection bias and
therefore greater external validity. Our study can be generalized to other elderly
Hispanic and NHW population of New Mexico and to other people from similar
backgrounds. The findings of our study indicate that one might prevent the
progression of prediabetes to diabetes with simple vitamin D supplements when
deficient. In addition, obesity, as a known risk factor for diabetes may also be
involved at an earlier stage of prediabetes (3). Therefore, preventing prediabetes
by vitamin D supplementation along with maintaining a healthy weight help delay
diabetes, maintain quality of life and reduce health care costs.
Future Directions
There is a great public health need to learn more about vitamin D deficiency and
its role in preventing diabetes. Our preliminary findings helped us understand
the positive relationship between vitamin D deficiency and prediabetes.
Therefore, it is important to analyze the rest of the sample population (N=581) so
that these results might be stronger and usefully translated to the general
population. We will include the participants’ usage of medications and other
supplements in the analysis. We will also consider an age and skin type
(Fitzpatrick scale) interaction in our full analysis of larger sample size. We plan
to use our Clinical and Translational Science Center (CTSC) grant to conduct the
rest of the analysis for more definitive answers.

We will publish our research

findings in a manuscript once the analysis is complete.
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